Overview

Basic information

Litigation

Active legal matters

Material Events

8-K disclosures

SEC Filings

Key regulatory docs

Insider Transactions

Ownership changes

Overview

Basic information

Litigation

Active legal matters

Material Events

8-K disclosures

SEC Filings

Key regulatory docs

Insider Transactions

Ownership changes

REGENERON PHARMACEUTICALS, INC. (REGN) Class Action Lawsuit (July 2026)

In Litigation

7:26cv6026 • July 16, 2026

Class Period Start

August 1, 2025

Class Period End

May 15, 2026

PSLRA Deadline

September 14, 2026

Case Allegations

10b5

Statutes of Repose

Aug 1, 2028

Country

United States

Court

Federal Court

Docket History

Oct 13, 2026

Appointment of Lead Plaintiff

The court has appointed a lead plaintiff to represent the interests of investors in the lawsuit. The lead plaintiff works with the attorneys handling the case, helps oversee the litigation, and represents the interests of the proposed class.

Jul 16, 2026

First Filed Complaint

A securities fraud class action complaint has been filed on behalf of certain investors in REGENERON PHARMACEUTICALS, INC..

Jul 16, 2026

First Filed Complaint

A securities fraud class action complaint has been filed on behalf of certain investors in REGENERON PHARMACEUTICALS, INC..

TOP